• No results found

18 results with keyword: 'car t cell long winding road solid tumors'

CAR-T cell. the long and winding road to solid tumors

In the first approach, target selectivity is ensured by a double recog- nition of two tumor antigens expressed by the same cell, while the second strategy implies the design of

Protected

N/A

12
0
0
2021
Ubiquitous Tracking. Ubiquitous Tracking. Martin Bauer Oberseminar Augmented Reality. 20. Mai 2003

Example GPS Ultrawideband GPS Truck is standing in front of building fighter moves inside building location camera sees fighter building consists of several parts... • There is no

Protected

N/A

23
0
0
2021
Current Progress in CAR-T Cell Therapy for Solid Tumors

Figure 1. Improving CAR-T cell trafficking and infiltration. 1) Targeting the tumor stroma or vasculature: tumor fibroblasts are depleted by FAP-targeting CAR-T cells to inhibit

Protected

N/A

13
0
0
2020
Current Progress in CAR-T Cell Therapy for Solid Tumors

through secretion of anti-PD-L1 antibodies from CAR-T cells. 2) CAR-T cell therapy is potently enhanced by PD-1 blockade. 3) Blockade with the IL-10/TGFβ receptor. 4)

Protected

N/A

13
0
0
2021
Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors

Key words: mesothelin, adoptive cell therapy, chimeric antigen receptor, solid

Protected

N/A

8
0
0
2021
Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities

However, there are still a number of barriers referred in this review for its application on solid tumors that we have to overcome, involving heterogenous targeting

Protected

N/A

11
0
0
2020
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors

Abstract: The success of chimeric antigen receptor-modified T-cell (CAR-T) therapy for B-cell lymphocyte malignancies targeting CD19 places it in a rapidly growing field in cancer

Protected

N/A

12
0
0
2020
Hong_unc_0153D_17522.pdf

Here, advances in adoptive T cell therapy and the evolution of chimeric antigen receptor T cells (CAR-Ts) against solid tumors, with an emphasis on CD30-specific CAR-Ts, will

Protected

N/A

143
0
0
2020
CAR T-Cell Therapy for Solid Tumors: How Far Are We from Reality?

In the inflammatory environment of a solid tumor, it upregulates the expression of the programmed cell death ligand ½ (PD-L1/2). This pathway is used by the tumor to induce

Protected

N/A

16
0
0
2021
Chimeric antigen receptors: unleashing a new age of anti-cancer therapy

the immunosuppressive microenvironment induced particularly by solid tumors, studies have augmented CAR T cell therapy with checkpoint inhibitors, such as anti-PD-1

Protected

N/A

6
0
0
2020
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment

ACT: Adoptive cell therapy; B-ALL: B-cells acute lymphoblastic leukemia; BMSCs: Bone marrow stromal cells; CAR: Chimeric antigen receptor; CASCs: Cancer-associated stromal cells;

Protected

N/A

8
0
0
2020
Original Article PiggyBac-modified CD19-expressing 4T1 cell line for the evaluation of CAR construct

Thus, we tried to develop a solid murine tumor 4T1 expressing CD19, which could offer an ideal cell line to study the killing mechanism of CAR-T cells against solid tumors both

Protected

N/A

8
0
0
2020
The Long and Winding Road

The heart of the substantive requirements was contained in Section 112.7, “Guidelines for the Preparation and Implementa- tion of a Spill Prevention, Control, and Countermeasure

Protected

N/A

7
0
0
2021
The Long and Winding Road

Key infrastructure variables were found to be: the degree of IT maturity within the Trust; the EHR products already on the market; the IT hardware budget at the Trust; the

Protected

N/A

362
0
0
2021
NoteBurner YouTube Video Downloader for Mac. Tutorial of NoteBurner YouTube Video Downloader for Mac

NoteBurner YouTube Video Downloader applies with a new type of searching mechanism, which will enable users to add videos not only by copying & pasting the link from YouTube

Protected

N/A

12
0
0
2021
Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward

In studies targeting solid tumors, CAR-T cells sur- mount challenges conferred by anti-inflammatory factors (e.g., TGF- β and IL-10), immune suppressor cells (Tregs, Bregs,

Protected

N/A

18
0
0
2020
CompTIA Mobility+ Boot Camp

The CompTIA Mobility+ exam covers mobile device management, troubleshooting, security, and network infrastructure.. It identifies IT professionals who can deploy, integrate, support

Protected

N/A

5
0
0
2021
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors

A newly established syngeneic solid tumor model of B16-CD20-CD46 murine melanoma cells stably expressing human antigens CD20 and CD46 as BiTE target antigen and measles virus

Protected

N/A

99
0
0
2021

Upload more documents and download any material studies right away!